Bacteriophage‐Loaded Poly(lactic‐co‐glycolic acid) Microparticles Mitigate Staphylococcus aureus Infection and Cocultures of Staphylococcus aureus and Pseudomonas aeruginosa
- 7 January 2022
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 11 (10) , 2102539-e2102539
Abstract
Lung infections caused by Gram‐positive Staphylococcus aureus (S. aureus) and coinfections caused by S. aureus and Gram‐negative Pseudomonas aeruginosa (P. aeruginosa) are challenging to treat, especially with the rise in the number of antibiotic‐resistant strains of these pathogens. Bacteriophage (phage) are bacteria‐specific viruses that can infect and lyse bacteria, providing a potentially effective therapy for bacterial infections. However, the development of bacteriophage therapy is impeded by limited suitable biomaterials that can facilitate effective delivery of phage to the lung. Here, the ability of porous microparticles engineered from poly(lactic‐co‐glycolic acid) (PLGA), a biodegradable polyester, to effectively deliver phage to the lung, is demonstrated. The phage‐loaded microparticles (phage‐MPs) display potent antimicrobial efficacy against various strains of S. aureus in vitro and in vivo, and arrest the growth of a clinical isolate of S. aureus in the presence of sputum supernatant obtained from cystic fibrosis patients. Moreover, phage‐MPs efficiently mitigate in vitro cocultures of S. aureus and P. aeruginosa and display excellent cytocompatibility with human lung epithelial cells. Therefore, phage‐MPs represents a promising therapy to treat bacterial lung infection.Keywords
Funding Information
- Centers for Disease Control and Prevention
- Cystic Fibrosis Foundation (CFF GARCIA17G0)
- National Institutes of Health (NIH R01 AR062920)
This publication has 49 references indexed in Scilit:
- CIM® monolithic anion-exchange chromatography as a useful alternative to CsCl gradient purification of bacteriophage particlesVirology, 2012
- Multiple Applications of Alamar Blue as an Indicator of Metabolic Function and Cellular Health in Cell Viability BioassaysSensors, 2012
- Cystic fibrosis: a mucosal immunodeficiency syndromeNature Medicine, 2012
- The human microbiome: at the interface of health and diseaseNature Reviews Genetics, 2012
- Pulmonary Bacteriophage Therapy on Pseudomonas aeruginosa Cystic Fibrosis Strains: First Steps Towards Treatment and PreventionPLOS ONE, 2011
- The Bacterial Cell EnvelopeCold Spring Harbor Perspectives in Biology, 2010
- Bacteriophage resistance mechanismsNature Reviews Microbiology, 2010
- Preventing biofilms of clinically relevant organisms using bacteriophageTrends in Microbiology, 2009
- Role of Particle Size in Phagocytosis of Polymeric MicrospheresPharmaceutical Research, 2008
- Cystic Fibrosis Sputum Supports Growth and Cues Key Aspects of Pseudomonas aeruginosa PhysiologyJournal of Bacteriology, 2005